-
1
-
-
0037174618
-
Alzheimer's disease is a synaptic failure
-
Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791.
-
(2002)
Science
, vol.298
, pp. 789-791
-
-
Selkoe, D.J.1
-
2
-
-
0025987048
-
Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
-
Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 30, 572-580.
-
(1991)
Ann Neurol
, vol.30
, pp. 572-580
-
-
Terry, R.D.1
Masliah, E.2
Salmon, D.P.3
Butters, N.4
Deteresa, R.5
Hill, R.6
Hansen, L.A.7
Katzman, R.8
-
3
-
-
84897954510
-
Is synaptic loss a unique hallmark of Alzheimer's disease?
-
Scheff SW, Neltner JH, Nelson PT (2014) Is synaptic loss a unique hallmark of Alzheimer's disease? Biochem Pharmacol 88, 517-528.
-
(2014)
Biochem Pharmacol
, vol.88
, pp. 517-528
-
-
Scheff, S.W.1
Neltner, J.H.2
Nelson, P.T.3
-
4
-
-
79956098248
-
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
-
Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Jr., Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M,Wagster MV, Phelps CH.(2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.
-
(2011)
Alzheimers Dement
, vol.7
, pp. 280-292
-
-
Sperling, R.A.1
Aisen, P.S.2
Beckett, L.A.3
Bennett, D.A.4
Craft, S.5
Fagan, A.M.6
Iwatsubo, T.7
Jack, C.R.8
Kaye, J.9
Montine, T.J.10
Park, D.C.11
Reiman, E.M.12
Rowe, C.C.13
Siemers, E.14
Stern, Y.15
Yaffe, K.16
Carrillo, M.C.17
Thies, B.18
Morrison-Bogorad, M.19
Wagster, M.V.20
Phelps, C.H.21
more..
-
5
-
-
0025269152
-
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
-
DeKosky ST, Scheff SW(1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Ann Neurol 27, 457-464.
-
(1990)
Ann Neurol
, vol.27
, pp. 457-464
-
-
Dekosky, S.T.1
Scheff, S.W.2
-
6
-
-
33646592555
-
Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally
-
Wurtman RJ, Ulus IH, Cansev M, Watkins CJ, Wang L, Marzloff G (2006) Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res 1088, 83-92.
-
(2006)
Brain Res
, vol.1088
, pp. 83-92
-
-
Wurtman, R.J.1
Ulus, I.H.2
Cansev, M.3
Watkins, C.J.4
Wang, L.5
Marzloff, G.6
-
7
-
-
36049020643
-
Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus
-
Sakamoto T, Cansev M, Wurtman RJ (2007) Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res 1182, 50-59.
-
(2007)
Brain Res
, vol.1182
, pp. 50-59
-
-
Sakamoto, T.1
Cansev, M.2
Wurtman, R.J.3
-
8
-
-
55549148744
-
Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils
-
Holguin S, Martinez J, Chow C, Wurtman R.(2008) Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils. FASEB J 22, 3938-3946.
-
(2008)
FASEB J
, vol.22
, pp. 3938-3946
-
-
Holguin, S.1
Martinez, J.2
Chow, C.3
Wurtman, R.4
-
9
-
-
84855963869
-
A specific multi-nutrient formulation enhances M1 muscarinic acetylcholine receptor responses. in vitro
-
Savelkoul PJ, Janickova H, Kuipers AA, Hageman RJ, Kamphuis PJ, Dolezal V, Broersen LM (2012) A specific multi-nutrient formulation enhances M1 muscarinic acetylcholine receptor responses in vitro. J Neurochem 120, 631-640.
-
(2012)
J Neurochem
, vol.120
, pp. 631-640
-
-
Savelkoul, P.J.1
Janickova, H.2
Kuipers, A.A.3
Hageman, R.J.4
Kamphuis, P.J.5
Dolezal, V.6
Broersen, L.M.7
-
10
-
-
33846304174
-
Dietary supplementation with uridine-5'-monophosphate (UMP), a membrane phosphatide precursor, increases acetylcholine level and release in striatum of aged rat
-
Wang L, Albrecht MA, Wurtman RJ (2007) Dietary supplementation with uridine-5'-monophosphate (UMP), a membrane phosphatide precursor, increases acetylcholine level and release in striatum of aged rat. Brain Res 1133, 42-48.
-
(2007)
Brain Res
, vol.1133
, pp. 42-48
-
-
Wang, L.1
Albrecht, M.A.2
Wurtman, R.J.3
-
11
-
-
0037739814
-
Combined uridine and choline administration improves cognitive deficits in spontaneously hypertensive rats
-
de Bruin NM, Kiliaan AJ, deWilde MC, Broersen LM (2003) Combined uridine and choline administration improves cognitive deficits in spontaneously hypertensive rats. Neurobiol Learn Mem 80, 63-79.
-
(2003)
Neurobiol Learn Mem
, vol.80
, pp. 63-79
-
-
De Bruin, N.M.1
Kiliaan, A.J.2
Dewilde, M.C.3
Broersen, L.M.4
-
12
-
-
84903704713
-
Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta-analysis
-
Lopes da Silva S, Vellas B, Elemans S, Luchsinger J, Kamphuis P, Yaffe K, Sijben J, Groenendijk M, Stijnen T.(2013) Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta-analysis. Alzheimers Dement 10, 485-502.
-
(2013)
Alzheimers Dement
, vol.10
, pp. 485-502
-
-
Lopes Da Silva, S.1
Vellas, B.2
Elemans, S.3
Luchsinger, J.4
Kamphuis, P.5
Yaffe, K.6
Sijben, J.7
Groenendijk, M.8
Stijnen, T.9
-
13
-
-
84899633911
-
Differences in nutritional status between very mild Alzheimer's disease patients and healthy controls
-
Olde Rikkert MGM, Verhey FR, Sijben JWC, Bouwman FH, Dautzenberg PLJ, Lansink M, Sipers WMW, van Asselt DZB, van Hees AMJ, Stevens M, Vellas B, Scheltens P (2014) Differences in nutritional status between very mild Alzheimer's disease patients and healthy controls. J Alzheimers Dis 41, 261-271.
-
(2014)
J Alzheimers Dis
, vol.41
, pp. 261-271
-
-
Olde Rikkert, M.G.M.1
Verhey, F.R.2
Sijben, J.W.C.3
Bouwman, F.H.4
Dautzenberg, P.L.J.5
Lansink, M.6
Sipers, W.M.W.7
Van Asselt, D.Z.B.8
Van Hees, A.M.J.9
Stevens, M.10
Vellas, B.11
Scheltens, P.12
-
14
-
-
84889770932
-
Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination
-
vanWijk N, Broersen LM, deWilde MC, Hageman RJ, Groenendijk M, Sijben JW, Kamphuis PJ (2014)Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination. J Alzheimers Dis 38, 459-479.
-
(2014)
J Alzheimers Dis
, vol.38
, pp. 459-479
-
-
Vanwijk, N.1
Broersen, L.M.2
Dewilde, M.C.3
Hageman, R.J.4
Groenendijk, M.5
Sijben, J.W.6
Kamphuis, P.J.7
-
15
-
-
72049130805
-
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
-
Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9, 119-128.
-
(2010)
Lancet Neurol
, vol.9
, pp. 119-128
-
-
Jack, C.R.1
Knopman, D.S.2
Jagust, W.J.3
Shaw, L.M.4
Aisen, P.S.5
Weiner, M.W.6
Petersen, R.C.7
Trojanowski, J.Q.8
-
17
-
-
33747760358
-
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
-
Scheff SW, Price DA, Schmitt FA, Mufson EJ (2006) Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 27, 1372-1384.
-
(2006)
Neurobiol Aging
, vol.27
, pp. 1372-1384
-
-
Scheff, S.W.1
Price, D.A.2
Schmitt, F.A.3
Mufson, E.J.4
-
18
-
-
73249116434
-
Efficacy of a medical food in mild Alzheimer's disease:Arandomized, controlled trial
-
Scheltens P, Kamphuis PJ, Verhey FR, Olde Rikkert MG, Wurtman RJ,Wilkinson D,Twisk JW,Kurz A. (2010) Efficacy of a medical food in mild Alzheimer's disease:Arandomized, controlled trial. Alzheimers Dement 6, 1-10 e11.
-
(2010)
Alzheimers Dement
, vol.6
, pp. 1e11-10e11
-
-
Scheltens, P.1
Kamphuis, P.J.2
Verhey, F.R.3
Olde Rikkert, M.G.4
Wurtman, R.J.5
Wilkinson, D.6
Twisk, J.W.7
Kurz, A.8
-
19
-
-
84863946102
-
Efficacy of Souvenaid in mild Alzheimer's disease: Results from a randomized, controlled trial
-
Scheltens P, Twisk J, Blesa R, Scarpini E, Vor Arnim C, Bongers A, Harrison J, Swinkels S, Stam C, DeWaal H,Wurtman R, Wieggers R, Vellas B, Kamphuis P. (2012) Efficacy of Souvenaid in mild Alzheimer's disease: Results from a randomized, controlled trial. J Alzheimers Dis 31, 225-236.
-
(2012)
J Alzheimers Dis
, vol.31
, pp. 225-236
-
-
Scheltens, P.1
Twisk, J.2
Blesa, R.3
Scarpini, E.4
Vor Arnim, C.5
Bongers, A.6
Harrison, J.7
Swinkels, S.8
Stam, C.9
Dewaal, H.10
Wurtman, R.11
Wieggers, R.12
Vellas, B.13
Kamphuis, P.14
-
20
-
-
84891795217
-
The S-Connect study: Results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease
-
Shah RC, Kamphuis PJ, Leurgans S, Swinkels SH, Sadowsky CH, Bongers A, Rappaport SA, Quinn JF, Wieggers RL, Scheltens P, Bennett DA (2013) The S-Connect study: Results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease. Alzheimers Res Ther 5, 59.
-
(2013)
Alzheimers Res Ther
, vol.5
, pp. 59
-
-
Shah, R.C.1
Kamphuis, P.J.2
Leurgans, S.3
Swinkels, S.H.4
Sadowsky, C.H.5
Bongers, A.6
Rappaport, S.A.7
Quinn, J.F.8
Wieggers, R.L.9
Scheltens, P.10
Bennett, D.A.11
-
21
-
-
0021271971
-
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
-
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
-
(1984)
Neurology
, vol.34
, pp. 939-944
-
-
McKhann, G.1
Drachman, D.2
Folstein, M.3
Katzman, R.4
Price, D.5
Stadlan, E.M.6
-
22
-
-
0016823810
-
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician
-
Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
-
(1975)
J Psychiatr Res
, vol.12
, pp. 189-198
-
-
Folstein, M.F.1
Folstein, S.E.2
McHugh, P.R.3
-
23
-
-
34548639338
-
A neuropsychological test battery for use in Alzheimer disease clinical trials
-
Harrison J, Minassian SL, Jenkins L, Black RS, Koller M, Grundman M. (2007) A neuropsychological test battery for use in Alzheimer disease clinical trials. Arch Neurol 64, 1323-1329.
-
(2007)
Arch Neurol
, vol.64
, pp. 1323-1329
-
-
Harrison, J.1
Minassian, S.L.2
Jenkins, L.3
Black, R.S.4
Koller, M.5
Grundman, M.6
-
24
-
-
0033193134
-
Development of a functional measure for persons with Alzheimer's disease: The disability assessment for dementia
-
Gelinas I, Gauthier L, McIntyre M, Gauthier S (1999) Development of a functional measure for persons with Alzheimer's disease: The disability assessment for dementia. Am J Occup Ther 53, 471-481.
-
(1999)
Am J Occup Ther
, vol.53
, pp. 471-481
-
-
Gelinas, I.1
Gauthier, L.2
McIntyre, M.3
Gauthier, S.4
-
25
-
-
0030853775
-
Standardization (external and internal) of HPLC assay for plasma homocysteine
-
Kuo K, Still R, Cale S, McDowell I (1997) Standardization (external and internal) of HPLC assay for plasma homocysteine. Clin Chem 43, 1653-1655.
-
(1997)
Clin Chem
, vol.43
, pp. 1653-1655
-
-
Kuo, K.1
Still, R.2
Cale, S.3
McDowell, I.4
-
26
-
-
0034833507
-
Measurement of homocysteine and other aminothiols in plasma: Advantages of using tris(2-carboxyethyl)phosphine as reductant compared with tri-n-butylphosphine
-
Krijt J, VackovaM, Kozich V. (2001) Measurement of homocysteine and other aminothiols in plasma: Advantages of using tris(2-carboxyethyl)phosphine as reductant compared with tri-n-butylphosphine. Clin Chem 47, 1821-1828.
-
(2001)
Clin Chem
, vol.47
, pp. 1821-1828
-
-
Krijt, J.1
Vackova, M.2
Kozich, V.3
-
27
-
-
42749100518
-
Cholinesterase inhibitors for Alzheimer's disease
-
Birks J. (2006) Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev, CD005593.
-
(2006)
Cochrane Database Syst Rev, CD
, pp. CD005593
-
-
Birks, J.1
-
28
-
-
36148957186
-
A review of compliance to treatment in Alzheimer's disease: Potential benefits of a transdermal patch
-
Small G, Dubois B (2007) A review of compliance to treatment in Alzheimer's disease: Potential benefits of a transdermal patch. Curr Med Res Opin 23, 2705-2713.
-
(2007)
Curr Med Res Opin
, vol.23
, pp. 2705-2713
-
-
Small, G.1
Dubois, B.2
|